Clinical Trials Logo

Bulimia clinical trials

View clinical trials related to Bulimia.

Filter by:

NCT ID: NCT03687346 Completed - Eating Disorder Clinical Trials

Biological Risk Factors for Onset of Binge Eating and Compensatory Behaviors

Start date: August 3, 2017
Phase:
Study type: Observational

The purpose of this proposed project is to test whether several biological factors (such as elevated brain reward region and attention region response to high-calorie foods, weaker inhibitory region response to high-calorie foods, habitual caloric deprivation, and elevated limbic region responsivity) increase the risk of problematic eating (bingeing and purging) in female adolescents.

NCT ID: NCT03680989 Completed - Eating Disorder Clinical Trials

A Pilot Test of Mood and Circadian Rhythm Mechanisms Driving Binge Eating

Start date: February 15, 2019
Phase: N/A
Study type: Interventional

Mood and circadian rhythm disruptions are associated with binge eating (BE). BE is a discrete, episodic behavior characterized by 1) eating an objectively large amount of food and 2) experiencing a subjective sense of loss of control. BE episodes are often preceded by negative mood states, and a subtype of individuals with BE has high levels of negative moods. This group has more comorbid psychopathology and a poorer response to treatment. Thus, understanding the role of negative mood is a critical area for research on BE. Individuals with BE demonstrate disruptions in several circadian rhythms, including diurnal meal timing, hormone patterns (e.g., daily cortisol rhythms), and mood variations. The most potent synchronizer of circadian rhythms is light. Thus, exposure to light may explain other phenomena that fluctuate similarly, such as mood and the occurrence of BE. Mood is subject to the influence of light, and BE is also influenced by exposure to bright light. It is unknown whether regulating circadian rhythms via regular exposure to light improves BE through its effects on mood or via changes in other biological or behavioral rhythms. This knowledge can inform the development of treatments targeting biobehavioral mechanisms that maintain BE and indicate for whom this may be most effective. This project aims to test the roles of negative mood and circadian rhythms in the relationship between light exposure and BE and identify subtypes of individuals in whom this effect is strong. The investigators hypothesize that individuals exposed to less natural bright light will experience more frequent BE, more negative mood, and a blunted morning cortisol response. The investigators further hypothesize that manipulating exposure to artificial bright light will reduce the frequency of BE and negative mood and increase the morning cortisol response. Finally, the investigators hypothesize that the effects of this artificial bright light exposure on BE frequency will be mediated by changes in negative mood, which itself will be accounted for by changes in circadian rhythms as indicated by the morning cortisol response. Additionally, the investigators have two moderation hypotheses: that the effects of artificial bright light exposure on BE will be greater for those who fit the high negative mood type than those who do not and that the effects will be greater for individuals with a blunted morning cortisol response at baseline than for those without.

NCT ID: NCT03678766 Completed - Obesity Clinical Trials

CHARGE: Controlling Hunger and ReGulating Eating

CHARGE
Start date: September 30, 2018
Phase: N/A
Study type: Interventional

The objectives of this proposed study are: 1) to evaluate feasibility and acceptability of a novel intervention, Regulation of Cues (ROC), and Cognitive Behavior Therapy (CBT), and 2) to evaluate the efficacy of both treatments on reduction of binge eating and weight loss among 120 Veterans with subclinical or clinical Binge Eating Disorder (BED) with comorbid overweight/obesity (OW/OB).

NCT ID: NCT03673540 Completed - Bulimia Nervosa Clinical Trials

Acquisition and Utilization of Skills Using Innovative Smartphone Application for Regular Eating

ACQUIRE
Start date: August 31, 2018
Phase: N/A
Study type: Interventional

The study seeks to evaluate the acceptability, feasibility, target engagement, and validity of an innovative smartphone application with ecological momentary interventions to augment cognitive behavioral therapy for bulimia nervosa.

NCT ID: NCT03604172 Completed - Clinical trials for Overweight and Obesity

Neural Response to Food Stimuli: fMRI Changes Following Cognitive Behavioral Therapy for Binge Eating Disorder

Start date: August 8, 2018
Phase: N/A
Study type: Interventional

The purpose of this research is to conduct a randomized controlled trial (RCT) assessing the impact of CBT on neural responses to binge eating stimuli.

NCT ID: NCT03540641 Completed - Clinical trials for Binge-Eating Disorder

Transcranial Magnetic Stimulation (TMS) in Binge Eating Disorder (BED)

TMS&BED
Start date: April 6, 2017
Phase: N/A
Study type: Interventional

This study evaluates de efficacy of 5Hz repetitive Transcranial Magnetic Stimulation (rTMS) applied on the left dorsolateral prefrontal cortex in patients with binge eating disorder.

NCT ID: NCT03539900 Completed - Clinical trials for Binge-Eating Disorder

Efficacy and Mechanisms of Naltrexone+Bupropion for Binge Eating Disorder

Start date: April 17, 2018
Phase: Phase 2/Phase 3
Study type: Interventional

This study will test the efficacy of naltrexone HCI and bupropion HCI (NB) versus placebo in patients with binge-eating disorder (BED), with or without obesity.

NCT ID: NCT03531112 Terminated - Weight Loss Clinical Trials

Reducing Binge Eating to Prevent Weight Gain in Black Women

Start date: January 12, 2019
Phase: N/A
Study type: Interventional

The purpose of the proposed study is to pilot a 6-month, cognitive-behavioral binge eating intervention, Appetite Awareness Training (AAT) to reduce binge eating and prevent weight gain for Black women with a BMI > 25 kg/m^2 and with weekly binge eating episodes. Intervention participants will receive a 8-week group AAT intervention, and will also receive bluetooth-connected scales for daily weighing. Participants will also receive tailored feedback on self-weighing frequency and weight change. The investigators will follow-up with participants at six months.

NCT ID: NCT03524443 Not yet recruiting - Clinical trials for Anorexia Nervosa/Bulimia

Evaluation of Art-therapy on Alexithymia in Patients Suffering From Anorexia Nervosa and From Bulimia

ALEXART
Start date: October 2018
Phase:
Study type: Observational

Alexithymia is often found in patients suffering from anorexia nervosa or from bulimia. Art-therapy is widely used in this indication without there is a study in the literature assessing it. ALEXART is an observational prospective multicenter cohort pilot study, assessing the effect at 3 months of art therapy on alexithymia, in patients presenting anorexia nervosa or bulimia.

NCT ID: NCT03471806 Enrolling by invitation - Bulimia Nervosa Clinical Trials

Dopamine Release to Food Reward in Bulimia Nervosa

Start date: February 16, 2018
Phase: N/A
Study type: Interventional

This study will assess the role of dopamine responses to food reward in Bulimia Nervosa patients, by performing simultaneous Positron Emission Tomography (PET) and Magnetic Resonance (MR) scanning. The dopamine response will be measured before and after treatment, and will be compared to healthy controls.